1 / 9

Exosome Diagnostic and Therapeutic Market to Garner $368 Million by 2022

Exosome Diagnostic and Therapeutic Market was valued at $39 million, and is expected to reach $368 million by 2022, supported by a CAGR of 37.8%.

Spooja
Download Presentation

Exosome Diagnostic and Therapeutic Market to Garner $368 Million by 2022

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Exosome Diagnostic and Therapeutic Market

  2. Exosome Diagnostic and Therapeutic Market by Application (Diagnostic and Therapeutic), Product (Instrument, Reagent and Software) and End-User (Cancer Institute, Hospital, Diagnostic Center, and Others) - Global Opportunity Analysis and Industry Forecasts, 2014-2022

  3. Introduction: Exosome Diagnostic and Therapeutic Marketwas valued at $39 million, and is expected to reach $368 million by 2022, supported by a CAGR of 37.8%. Exosomes play a key role in facilitating cell-to-cell communication in the cancer prognosis. It suppresses the immune function by inducing apoptosis of activated cytotoxic T cells, which enable tumor progression in the human body. In addition, exosomes also stimulate the angiogenesis and migration leading to metastasis. Moreover, exosomes trigger apoptosis in anti-tumor immune cells through tumor necrosis factor pathways. Furthermore, healthcare professionals use exosomes to diagnose cancer, which helps in profiling genetic changes in tumors and also prevent the spread of the disease.

  4. Segmentation: This report covers information on various types of exosome products such as instruments, reagents, and software that are manufactured for medical and research purposes in compliance with the European Medical Association (EMA), the U.S. Food and Drugs Administration (FDA), ConformitEuropene (CE) and other regulatory authorities. Moreover, this market also focuses on the application and end users of the market. By application, the market is segmented into diagnostic and therapeutic applications. Based on end user, the market is categorized into cancer institute, hospital, diagnostic centers, and others. Get Sample Report@ https://www.alliedmarketresearch.com/request-sample/1723

  5. Key Players: • Aethlon Medical, Inc. (U.S.) • Exosome Diagnostics Inc. (U.S.) • NanoSomix Inc. (U.S.) • Thermo Fisher Scientific Inc. (U.S.) • Malvern Instruments Ltd. (U.K,) • System Biosciences Inc. (U.S.) • NX Pharmagen (U.S.) • Sistemic Inc. (U.K.) • Capricor Therapeutics (U.S.) • Exiqon A/S (Denmark). Read More@ https://www.alliedmarketresearch.com/exosome-diagnostic-and-therapeutic-market

  6. About Us: Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small- & medium-scale enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain. Allied Market Research provides one-stop solution right from data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients understand the significance and impact of market dynamics. The company applies client’s insight on the factors such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligence support to help clients transform into a prominent business firm.

  7. Contact Us: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States Toll Free (USA/Canada): +1-800-792-5285, +1-503-894-6022, +1-503-446-114 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1⟨855⟩550-5975 help@alliedmarketresearch.com

  8. Thank You Access Full Summary @https://www.prnewswire.com/news-releases/exosome-diagnostic-and-therapeutic-market-would-reach-367-million-by-2022-globally---allied-market-research-596028451.html

More Related